Top Markets
#1 GoPlus Security GoPlus Security +31.58%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.85%
#3 Tutorial Tutorial +18.60%
#4 Status Status +15.77%
#5 Pons Pons +14.32%
#6 Wrapped NXM Wrapped NXM +14.12%
#7 Verus Coin Verus Coin +12.97%
#8 o1.exchange o1.exchange +10.06%
#9 SkyAI SkyAI +9.28%
#10 DMT-NAT DMT-NAT +8.92%
Coin of the day
GoPlus Security GoPlus Security
Settings
Language
ENGLISH
Currency
USD
Theme
America Great Health America Great Health

America Great Health

AAGH
Rank in Stocks #34041
Operating as a U.S.-based biotechnology company, America Great Health (AAGH)... Operating as a U.S.-based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio including AI cloud computing-driven diagnostic and medical devices, cell therapies, regenerative medicine, and supplements. The company, which originated as Crown Marketing, adopted the name America Great Health in March 2017. Established in 2013, AAGH's headquarters are located in Alhambra, California.
Share Price
$0.0003
Last synced: 2026-08-14
Market Cap
$6.35M
Change (1 day)
0.00%
Change (1 year)
-40.00%
Country
US
Trade America Great Health (AAGH)

Category

Healthcare
P/E ratio for America Great Health (AAGH)
P/E ratio as of 2026 TTM: 0
According to America Great Health latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for America Great Health from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 18.38 -
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.